Introducing Milky Way Biotech - a cutting-edge startup comprising a team of highly skilled researchers from the Technical University of Denmark. Our mission is to eradicate lactose intolerance through the development of a revolutionary single-pill genetic therapy. Currently, we are conducting pre-clinical studies to ensure the safety and efficacy of our treatment. We invite you to follow us on our website and social media platforms to stay up-to-date with our progress. Join us on our quest to make lactose intolerance a thing of the past! ✔ Admitted to European Venture Program (EVP) 2023 Summer ✔ Completed DTU Skylab Ignite Program 2023 Spring ✔ Completed KU Health Innovators Program 2023 ✔ Funded by BioInnovation Institute (BII)
